Triple drug combination shows promise against fatal blood cancer
Acute myeloid leukemia (AML) is an aggressive blood cancer that remains difficult to treat. While targeted therapies have improved outcomes for some patients, many relapse when a small population of cancer stem cells survives ...
20 hours ago
0
3









